Which has higher valuation & earnings, PSNL or BLLN?

Billiontoone has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Personalis $69.65M 15.39 -$81.27M -$1.02 N/A Billiontoone $305.11M 15.66 $7.45M $0.55 188.90

Does the media favor PSNL or BLLN?

In the previous week, Billiontoone had 3 more articles in the media than Personalis. MarketBeat recorded 9 mentions for Billiontoone and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat Billiontoone's score of -0.55 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Is PSNL or SHC more profitable?

Sotera Health has a net margin of 9.91% compared to Personalis' net margin of -148.11%. Sotera Health's return on equity of 39.73% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Personalis -148.11% -43.52% -32.92% Sotera Health 9.91% 39.73% 7.05%

Does the media refer more to PSNL or SHC?

In the previous week, Personalis had 2 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for Personalis and 4 mentions for Sotera Health. Personalis' average media sentiment score of 1.28 beat Sotera Health's score of 0.91 indicating that Personalis is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Sotera Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is PSNL or CELC more profitable?

Celcuity has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Personalis' return on equity of -43.52% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Personalis -148.11% -43.52% -32.92% Celcuity N/A -244.61% -50.22%

Does the media refer more to PSNL or CELC?

In the previous week, Personalis had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for Personalis and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.49 beat Personalis' score of 1.28 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, RDNT or PSNL?

RadNet has higher revenue and earnings than Personalis. RadNet is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.14B 2.15 -$18.65M -$0.18 N/A Personalis $69.65M 15.39 -$81.27M -$1.02 N/A

Is RDNT or PSNL more profitable?

RadNet has a net margin of -0.66% compared to Personalis' net margin of -148.11%. RadNet's return on equity of 2.77% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.66% 2.77% 0.97% Personalis -148.11% -43.52% -32.92%

Does the media favor RDNT or PSNL?

In the previous week, RadNet had 1 more articles in the media than Personalis. MarketBeat recorded 7 mentions for RadNet and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat RadNet's score of 0.72 indicating that Personalis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, VCYT or PSNL?

Veracyte has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Veracyte $517.15M 7.58 $66.35M $1.09 45.06 Personalis $69.65M 15.39 -$81.27M -$1.02 N/A

Is VCYT or PSNL more profitable?

Veracyte has a net margin of 16.25% compared to Personalis' net margin of -148.11%. Veracyte's return on equity of 9.07% beat Personalis' return on equity. Company Net Margins Return on Equity Return on Assets Veracyte 16.25% 9.07% 8.38% Personalis -148.11% -43.52% -32.92%

Does the media refer more to VCYT or PSNL?

In the previous week, Veracyte and Veracyte both had 6 articles in the media. Personalis' average media sentiment score of 1.28 beat Veracyte's score of 1.14 indicating that Personalis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Personalis 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Personalis (PSNL) Competitors

$10.23 +0.64 (+6.72%)

As of 12:06 PM Eastern

Compare

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

Should you buy Personalis stock or one of its competitors? MarketBeat compares Personalis with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Personalis include Billiontoone (BLLN), Sotera Health (SHC), Celcuity (CELC), RadNet (RDNT), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does Personalis compare to Billiontoone?

Personalis (NASDAQ:PSNL) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

61.9% of Personalis shares are owned by institutional investors. 4.2% of Personalis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Billiontoone has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Billiontoone's return on equity of 0.00% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Billiontoone	N/A	N/A	N/A

Personalis currently has a consensus price target of $11.00, suggesting a potential upside of 7.48%. Billiontoone has a consensus price target of $125.29, suggesting a potential upside of 20.59%. Given Billiontoone's higher probable upside, analysts clearly believe Billiontoone is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	15.39	-$81.27M	-$1.02	N/A
Billiontoone	$305.11M	15.66	$7.45M	$0.55	188.90

In the previous week, Billiontoone had 3 more articles in the media than Personalis. MarketBeat recorded 9 mentions for Billiontoone and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat Billiontoone's score of -0.55 indicating that Personalis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Summary

Billiontoone beats Personalis on 11 of the 15 factors compared between the two stocks.

How does Personalis compare to Sotera Health?

Personalis (NASDAQ:PSNL) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Personalis currently has a consensus price target of $11.00, suggesting a potential upside of 7.48%. Sotera Health has a consensus price target of $20.29, suggesting a potential upside of 24.25%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts clearly believe Sotera Health is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Sotera Health has a net margin of 9.91% compared to Personalis' net margin of -148.11%. Sotera Health's return on equity of 39.73% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Sotera Health	9.91%	39.73%	7.05%

Personalis has a beta of 2.27, suggesting that its stock price is 127% more volatile than the broader market. Comparatively, Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market.

In the previous week, Personalis had 2 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for Personalis and 4 mentions for Sotera Health. Personalis' average media sentiment score of 1.28 beat Sotera Health's score of 0.91 indicating that Personalis is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Sotera Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

61.9% of Personalis shares are owned by institutional investors. Comparatively, 91.0% of Sotera Health shares are owned by institutional investors. 4.2% of Personalis shares are owned by insiders. Comparatively, 15.4% of Sotera Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Sotera Health has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	15.39	-$81.27M	-$1.02	N/A
Sotera Health	$1.16B	4.00	$77.94M	$0.41	39.82

Summary

Sotera Health beats Personalis on 12 of the 16 factors compared between the two stocks.

How does Personalis compare to Celcuity?

Personalis (NASDAQ:PSNL) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Personalis has a beta of 2.27, meaning that its share price is 127% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, meaning that its share price is 90% less volatile than the broader market.

Personalis has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Personalis	$69.65M	15.39	-$81.27M	-$1.02	N/A
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

Celcuity has a net margin of 0.00% compared to Personalis' net margin of -148.11%. Personalis' return on equity of -43.52% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Personalis	-148.11%	-43.52%	-32.92%
Celcuity	N/A	-244.61%	-50.22%

In the previous week, Personalis had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for Personalis and 3 mentions for Celcuity. Celcuity's average media sentiment score of 1.49 beat Personalis' score of 1.28 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

61.9% of Personalis shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 4.2% of Personalis shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Personalis presently has a consensus target price of $11.00, suggesting a potential upside of 7.48%. Celcuity has a consensus target price of $152.09, suggesting a potential upside of 73.76%. Given Celcuity's stronger consensus rating and higher probable upside, analysts clearly believe Celcuity is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

Summary

Personalis beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does Personalis compare to RadNet?

RadNet (NASDAQ:RDNT) and Personalis (NASDAQ:PSNL) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Personalis has a beta of 2.27, indicating that its stock price is 127% more volatile than the broader market.

77.9% of RadNet shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

RadNet has higher revenue and earnings than Personalis. RadNet is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.14B	2.15	-$18.65M	-$0.18	N/A
Personalis	$69.65M	15.39	-$81.27M	-$1.02	N/A

RadNet has a net margin of -0.66% compared to Personalis' net margin of -148.11%. RadNet's return on equity of 2.77% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
Personalis	-148.11%	-43.52%	-32.92%

RadNet presently has a consensus price target of $87.43, suggesting a potential upside of 49.33%. Personalis has a consensus price target of $11.00, suggesting a potential upside of 7.48%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Personalis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

In the previous week, RadNet had 1 more articles in the media than Personalis. MarketBeat recorded 7 mentions for RadNet and 6 mentions for Personalis. Personalis' average media sentiment score of 1.28 beat RadNet's score of 0.72 indicating that Personalis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

RadNet beats Personalis on 13 of the 17 factors compared between the two stocks.

How does Personalis compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Personalis (NASDAQ:PSNL) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

61.9% of Personalis shares are held by institutional investors. 1.4% of Veracyte shares are held by company insiders. Comparatively, 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Veracyte currently has a consensus price target of $47.57, suggesting a potential downside of 3.13%. Personalis has a consensus price target of $11.00, suggesting a potential upside of 7.48%. Given Personalis' stronger consensus rating and higher possible upside, analysts plainly believe Personalis is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Personalis	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57

Veracyte has a net margin of 16.25% compared to Personalis' net margin of -148.11%. Veracyte's return on equity of 9.07% beat Personalis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Personalis	-148.11%	-43.52%	-32.92%

Veracyte has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market. Comparatively, Personalis has a beta of 2.27, indicating that its stock price is 127% more volatile than the broader market.

In the previous week, Veracyte and Veracyte both had 6 articles in the media. Personalis' average media sentiment score of 1.28 beat Veracyte's score of 1.14 indicating that Personalis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Personalis	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	7.58	$66.35M	$1.09	45.06
Personalis	$69.65M	15.39	-$81.27M	-$1.02	N/A

Summary

Veracyte and Personalis tied by winning 8 of the 16 factors compared between the two stocks.

Get Personalis News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PSNL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PSNL vs. The Competition

Export

Metric	Personalis	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.07B	$5.85B	$6.50B	$12.37B
Dividend Yield	N/A	0.69%	2.67%	5.66%
P/E Ratio	-10.03	8.67	24.01	24.71
Price / Sales	15.39	22.41	540.55	165.59
Price / Cash	N/A	8.43	27.48	37.92
Price / Book	3.48	4.13	10.55	6.85
Net Income	-$81.27M	$99.67M	$3.56B	$337.45M
7 Day Performance	1.93%	0.95%	1.54%	2.70%
1 Month Performance	60.91%	3.92%	2.48%	4.60%
1 Year Performance	70.28%	118.21%	26.49%	32.81%

Personalis Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PSNL Personalis	3.1746 of 5 stars	$10.23 +6.7%	$11.00 +7.5%	+59.6%	$1.07B	$69.65M	N/A	400	News Coverage Positive News Analyst Downgrade Gap Up
BLLN Billiontoone	3.6449 of 5 stars	$94.43 -2.8%	$125.29 +32.7%	N/A	$4.47B	$305.11M	171.69	620
SHC Sotera Health	3.7102 of 5 stars	$15.86 +1.5%	$20.29 +27.9%	+41.6%	$4.45B	$1.16B	38.68	3,000
CELC Celcuity	3.2526 of 5 stars	$87.43 -1.0%	$152.09 +74.0%	+631.2%	$4.31B	N/A	N/A	40	Positive News
RDNT RadNet	3.2794 of 5 stars	$54.16 -0.3%	$87.43 +61.4%	+2.3%	$4.27B	$2.14B	N/A	11,264

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PSNL) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Personalis (PSNL) Competitors

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

How does Personalis compare to Billiontoone?

Summary

How does Personalis compare to Sotera Health?

Summary

How does Personalis compare to Celcuity?

Summary

How does Personalis compare to RadNet?

Summary

How does Personalis compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSNL vs. The Competition

Personalis Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Personalis (PSNL) Competitors

PSNL vs. BLLN, SHC, CELC, RDNT, and VCYT

How does Personalis compare to Billiontoone?

Do insiders & institutionals hold more shares of PSNL or BLLN?

Is PSNL or BLLN more profitable?

Do analysts recommend PSNL or BLLN?

Which has higher valuation & earnings, PSNL or BLLN?

Does the media favor PSNL or BLLN?

Summary

How does Personalis compare to Sotera Health?

Do analysts recommend PSNL or SHC?

Is PSNL or SHC more profitable?

Which has more risk & volatility, PSNL or SHC?

Does the media refer more to PSNL or SHC?

Do institutionals & insiders hold more shares of PSNL or SHC?

Which has stronger earnings & valuation, PSNL or SHC?

Summary

How does Personalis compare to Celcuity?

Which has more risk & volatility, PSNL or CELC?

Which has better valuation and earnings, PSNL or CELC?

Is PSNL or CELC more profitable?

Does the media refer more to PSNL or CELC?

Do institutionals and insiders hold more shares of PSNL or CELC?

Do analysts rate PSNL or CELC?

Summary

How does Personalis compare to RadNet?

Which has more volatility and risk, RDNT or PSNL?

Do insiders and institutionals hold more shares of RDNT or PSNL?

Which has better valuation & earnings, RDNT or PSNL?

Is RDNT or PSNL more profitable?

Do analysts prefer RDNT or PSNL?

Does the media favor RDNT or PSNL?

Summary

How does Personalis compare to Veracyte?

Do insiders & institutionals hold more shares of VCYT or PSNL?

Do analysts prefer VCYT or PSNL?

Is VCYT or PSNL more profitable?

Which has more risk & volatility, VCYT or PSNL?

Does the media refer more to VCYT or PSNL?

Which has higher earnings and valuation, VCYT or PSNL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSNL vs. The Competition

Personalis Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools